1. .LWVOLRÀOL]DGRV
8QVyORHQVDR'HWHFFLyQGHP~OWLSOHVSDWyJHQRV

2. 'LDJQyVWLFR
molecular
VIASURE®
Real Time PCR Detection Kit ha sido diseñado para
HOGLDJQyVWLFRGHHQIHUPHGDGHVLQIHFFLRVDVFDXVDGDVSRU
GLIHUHQWHVSDWyJHQRVHQPXHVWUDVKXPDQDV
Esta gama se basa en la actividad 5’ exonucleasa de la
7DT'1$3ROLPHUDVD3DUDOOHYDUDFDERHVWDUHDFFLyQVRQ
necesarios dos cebadores y una sonda, complementarios
D OD VHFXHQFLD D DPSOLÀFDU RPR UHVXOWDGR GH OD
DPSOLÀFDFLyQ VH JHQHUD XQ LQFUHPHQWR HQ OD VHxDO
ÁXRUHVFHQWHSURSRUFLRQDODODFDQWLGDGGHVHFXHQFLD'1$
diana presente en la muestra, que puede ser medida en un
amplio rango de equipos Real Time PCR.
VIASURE®
Real Time PCR Detection Kit contiene en cada
pocillo todos los reactivos necesarios para realizar el ensayo
35 D WLHPSR UHDO FHEDGRUHVVRQGDV HVSHFtÀFDV G173V
WDPSyQHQ]LPDV HQIRUPDWRHVWDELOL]DGRORTXHSHUPLWH
su envío y almacenamiento a temperatura ambiente.
Kits Hyperplex, multiplex y monoplex que proporcionan la
Pi[LPD ÁH[LELOLGDG FRPSDWLELOLGDG FRQ ORV SULQFLSDOHV
termocicladores de sistema abierto.
/DWpFQLFD35HQWLHPSRUHDO
tiene como objetivo obtener
una gran cantidad de copias
GHXQIUDJPHQWRGH$'1
HVSHFtÀFRDSDUWLUGH
una cantidad mínima.
INTRODUCCIÓN
“
Metodología
$xDGLUǍOGHVROXFLyQWDPSyQHQFDGDSRFLOORSDUDODUHKLGUDWDFLyQ
(QFDGDVHULHGHPXHVWUDVDDQDOL]DUVHGHEHQLQFOXLUXQFRQWUROSRVLWLYRXQRQHJDWLYR
$xDGLUǍ/GH0XHVWUDGH'1$51$RQWURO3RVLWLYRRQWURO1HJDWLYR
RORFDUODVWLUDVHQHOWHUPRFLFODGRUHLQLFLDUHOSURWRFRORHVSHFtÀFR
,QWHUSUHWDFLyQGHUHVXOWDGRV
1
2
3
4
2

3. 3
,QIHFFLRQHVJDVWURLQWHVWLQDOHV
7LSR 5HI 'HVFULSFLyQ
0XOWLSOH[ Virus NOR Norovirus GI+GII (1
)
%DFWHULDV SCY Salmonella, Campylobacter Yersinia enterocolitica
SCS Salmonella, Campylobacter Shigella/EIEC
/- Campylobacter coli, C. lari C. jejuni (1
)
AEY Aeromonas spp + Yersinia enterocolitica
ESE E. coli ETEC + EIEC (1
)
EEE E. coli EHEC, EPEC EIEC (1
)
ECT E. coli typing (2 pocillos) (1
)
(E. coli ETEC + EIEC) + (E. coli EHEC, EPEC EIEC)
/$ H. pylori + Clarithromycin resistance
CDA ORVWULGLXPGLIÀFLOHWR[LQV$%
Parásitos KGE Cryptosporidium, Giardia E. histolytica (1
)
%/' Blastocystis hominis + Dientamoeba fragilis (1
)
3Uy[LPDPHQWH
9LEULRGLIIHUHQWLDWLRQV. cholerae, 9SDUDKDHPROWLFXV 9YXOQLÀFXV
7LSR 5HI 'HVFULSFLyQ
0RQRSOH[ Virus ADV Adenovirus
ATV Astrovirus
NOG Norovirus GI
NOP Norovirus GII
RTV Rotavirus
SAV Sapovirus
%DFWHULDV CAM Campylobacter
CDS ORVWULGLXPGLIÀFLOH (1
)
7% ORVWULGLXPGLIÀFLOHWR[%(1
)
CIA ORVWULGLXPGLIÀFLOHWR[LQV$%(1
)
PYR Helicobacter pylori (1
)
SAM Salmonella
SHY Shigella/EIEC (Enteroinvasive Escherichia coli)
YER Yersinia enterocolitica
Parásitos KRY Cryptosporidium
GIA Giardia lamblia
ETH Entamoeba histolytica
ETD Entamoeba dispar
DIE Dientamoeba fragilis
Multiplex Monoplex
(1
'LVSRQLEOHNLWFRQFRQWUROGHH[WUDFFLyQ 2
6yORSDUDXVRHQLQYHVWLJDFLyQ

4. ,QIHFFLRQHVUHVSLUDWRULDV
7LSR 5HI 'HVFULSFLyQ
0XOWLSOH[ Virus ,$% )OX$)OX%
$%5 )OX$)OX% 569(1
)
RSV 569$%(1
)
H13 Flu Typing I (H1N1 H3N2)
HXN Flu Typing II (H1N1, H5N1, H3N2 H7N9)
RPA Respiratory Viral Panel I (2 pocillos) (1
)
)OX$)OX% 569 +1+1+1 +1
PIZ 3DUDLQÁXHQ]D SRFLOORV
$0% $GHQRYLUXV0HWDSQHXPRYLUXV %RFDYLUXV
RHE Rhinovirus + Enterovirus
MER MERS Coronavirus (2 pocillos)
COR RURQDYLUXV (1/ +.8
%DFWHULDV %'7 Bordetella (B. pertussis, B. parapertussis B. holmesii) (1
)
0/ C. pneumoniae, M. pneumoniae L. pneumophila (1
) (2
)
HSM +LQÁXHQ]DH6SQHXPRQLDH 0FDWDUUKDOLV (1
)
3Uy[LPDPHQWH
- M. tuberculosis complex + non-tuberculosis mycobacteria (1
)
7LSR 5HI 'HVFULSFLyQ
0RQRSOH[ Virus %96 %RFDYLUXV
MPV Human metapneumovirus
YIA ,QÁXHQ]D$
HNV ,QÁXHQ]D$ +1 SGP(1
)
,% ,QÁXHQ]D%
PIA 3DUDLQÁXHQ]D
3,% 3DUDLQÁXHQ]D
PIC 3DUDLQÁXHQ]D
PID 3DUDLQÁXHQ]D
RSA RSV A
56% 569%
%DFWHULDV /*1 Legionella pneumophila (1
)
MTC M. tuberculosis complex (1
)
Hongos JIR Pneumocystis jirovecii (q)(1
)
4
Multiplex Monoplex
(1
'LVSRQLEOHNLWFRQFRQWUROGHH[WUDFFLyQ 2
6yORSDUDXVRHQLQYHVWLJDFLyQ(q) Cuantitativo

5. 5
(QIHUPHGDGHVWUDQVPLWLGDVSRUYHFWRUHV
Resistencias antimicrobianas
5HI 'HVFULSFLyQ
0XOWLSOH[ ZDC Zika, Dengue Chikungunya Virus (1
)
DES Dengue Serotyping (Dengue 1, 4 2, 3) (2 pocillos)
7%' 7LFN%RUQH'LVHDVHV (3 pocillos) (1
)
(Borrelia, Anaplasma Coxiella) +
(Rickettsia, Babesia Ehrlichia) 7%(9)
%$ Borrelia, Anaplasma Coxiella (1
)
7LSR 5HI 'HVFULSFLyQ
0RQRSOH[ Virus ZIK Zika Virus
DEN Dengue Virus
CHI Chikungunya Virus
WNV West Nile Virus
FEV Yellow Fever (1
)
MYV Mayaro Virus (1
)
CCV Crimean-Congo Haemorrhagic Fever
JEV Japanese Encephalitis Virus
Parásitos CHA 7USDQRVRPDFUX]L(Chagas)
0$' 0DODULDGLIIHUHQWLDWLRQ SRFLOORV
(P. malariae, P. knowlesi P. ovale) +
(P. falciparum, P. vivax)
0$/ 0DODULD(q)(1
)
RPLQJVRRQ
- Oropouche Virus
/HLVKPDQLD
5HI 'HVFULSFLyQ
0XOWLSOH[ VAN Vancomycin resistance
/$ H. pylori + Clarithromycin resistance
MSA Methicillin-resistant Staphylococcus aureus (1
)
RPLQJVRRQ
DUEDSHQHPDVHSURGXFLQJ(QWHUREDFWHULDFHDH SRFLOORV
(NDM+VIM) + (OXA, KPC IMP)
(1
'LVSRQLEOHNLWFRQFRQWUROGHH[WUDFFLyQ 2
6yORSDUDXVRHQLQYHVWLJDFLyQ(q) Cuantitativo

6. Transplantes, meningitis otros
7UDQVPLVLyQVH[XDO
5HI 'HVFULSFLyQ
0XOWLSOH[ Transplantes %-9 %.-9LUXV
HHZ Herpes Virus 1, Herpes Virus 2 Varicela Zoster Virus (1
)
HHV Human Herpes Virus 6, 7 8
Meningitis HNS +LQÁXHQ]DH1PHQLQJLWLGLV 6SQHXPRQLDH (1
)
6/( S. agalactiae, L. monocytogenes E. coli
3Uy[LPDPHQWH
- Paperas, Enterovirus Parechovirus
5HI 'HVFULSFLyQ
0XOWLSOH[ STD (QIHUPHGDGHVGHWUDQVPLVLyQVH[XDO SRFLOORV (1
)
(1JRQRUUKRHDHWUDFKRPDWLV 0JHQLWDOXP +
(T. vaginalis, U. urealyticum, U. parvum M. hominis)
HHT Herpes virus 1, Herpes virus 2 Treponema pallidum
HCT H. ducreyi + C. trachomatis /*9 (1
) (2
)
CGT C. albicans, G. vaginalis T. vaginalis
HPV Human Papilloma Virus 16 + 18 (1
)
5HI 'HVFULSFLyQ
0RQRSOH[ *%6 Streptococcus B
TPA Treponema pallidum (1
)
Multiplex Monoplex
6
(1
'LVSRQLEOHNLWFRQFRQWUROGHH[WUDFFLyQ 2
6yORSDUDXVRHQLQYHVWLJDFLyQ

7. 7
Panels
VIASURE
Panels
Real Time PCR en tiempo real capaz de detectar
simultáneamente virus, bacterias y/o parásitos.
'HWHFFLyQ GH P~OWLSOHV GLDQDV HQ XQ
DPSOLRUDQJRGHSDQHOHVP~OWLSOHV
0HMRUDGHOPDQHMRGHOSDFLHQWHPDRU
rentabilidad.
3DQHOHV HQIRFDGRV D VtQGURPHV HVSHFtÀFRV LQIHFFLRVRV
FDSDFHV GH DQDOL]DU GH IRUPD VLPXOWiQHD P~OWLSOHV
SDWyJHRQVHQXQD~QLFDPXHVWUD
)OX$)OX%
569$%
Flu Typing II (H1N1, H5N1, H3N2 H7N9)
$GHQRYLUXV0HWDSQHXPRYLUXV %RFDYLUXV
RURQDYLUXV 1/2 +.8
3DULQÁXHQ]D SRFLOORV
C. pneumoniae, M. pneumoniae
L. pneumophila
Ejemplo. Panel respiratorio.
1 Tira
1 Paciente
22 Dianas

8. 3DQHOJDVWURLQWHVWLQDO,(1
) 5HI*3
3DQHOJDVWURLQWHVWLQDO,,(1
) 5HI*3
3DQHOJDVWURLQWHVWLQDO,,, (1
) 5HI*3
3DQHOJDVWURLQWHVWLQDO,9(1
) 5HI*3
Salmonella, Campylobacter Y. enterocolitica
Shigella/EIEC
Cryptosporidium, Giardia E. histolytica
Norovirus GI + GII
Rotavirus
Adenovirus
Astrovirus
Sapovirus
Salmonella, Campylobacter Shigella/EIEC
Aeromonas spp. + Yersinia enterocolitica
E. coli typing (2 tubes)
ORVWULGLXPGLIÀFLOH
ORVWULGLXPGLIÀFLOHWR[%
Cryptosporidium, Giardia E. histolytica
Blastocystis hominis + Dientamoeba fragilis
Salmonella, Campylobacter Shigella/EIEC
Aeromonas spp. + Yersinia enterocolitica
E. coli ETEC + EIEC
E. coli EHEC, EPEC EIEC
ORVWULGLXPGLIÀFLOHWR[LQV$%
Salmonella, Campylobacter Yersinia enterocolitica
Campylobacter coli, C. lari C. jejuni
E. coli EHEC, EPEC EIEC
Paciente #1
Paciente #1
Paciente #2
Paciente #2
8
Panels
(1
'LVSRQLEOHNLWFRQFRQWUROGHH[WUDFFLyQ 2
6yORSDUDXVRHQLQYHVWLJDFLyQ
Paciente #1
Paciente #1

9. 9
3DQHOUHVSLUDWRULR,(1
) 5HI53
3DQHOUHVSLUDWRULR,,(1
) (2
) 5HI53
3DQHOUHVSLUDWRULR,,,(1
) (2
) 5HI53
3DQHOUHVSLUDWRULR,9(1
) 5HI53
)OX$ÁX% 569
Rhinovirus + Enterovirus
$GHQRYLUXV0HWDSQHXPRYLUXV %RFDYLUXV
MERS Coronavirus (2 tubes)
RURQDYLUXV 1/2 +.8
3DUDLQÁXHQ]D WXEHV
)OX$)OX%
569$%
Flu Typing II (H1N1, H5N1, H3N2 H7N9)
$GHQRYLUXV0HWDSQHXPRYLUXV %RFDYLUXV
RURQDYLUXV 1/2 +.8
3DUDLQÁXHQ]D WXEHV
C. pneumoniae, M. pneumoniae L. pneumophila
)OX$)OX% 569
3DUDLQÁXHQ]D WXEHV
$GHQRYLUXV0HWDSQHXPRYLUXV %RFDYLUXV
Rhinovirus + Enterovirus
RURQDYLUXV 1/2 +.8
C. pneumoniae, M. pneumoniae L. pneumophila
+LQÁXHQ]DH6SQHXPRQLDH 0FDWDUUKDOLV
)OX$%
,QÁXHQ]D+1
569$%
3DUDLQÁXHQ]D WXEHV
$GHQRYLUXV0HWDSQHXPRYLUXV %RFDYLUXV
Rinovirus + Enterovirus
RURQDYLUXV 1/2 +.8
(1
'LVSRQLEOHNLWFRQFRQWUROGHH[WUDFFLyQ 2
6yORSDUDXVRHQLQYHVWLJDFLyQ
Paciente #1
Paciente #1
Paciente #1
Paciente #1

10. 3DQHOGHWUDQVPLVLyQVH[XDO,(1
) (2
) 5HI63
3DQHOWURSLFDO,(1
) 5HI73
1JRQRUUKRHDHWUDFKRPDWLV 0JHQLWDOXP
T. vaginalis, U. urealyticum, U. parvum M. hominis
Herpes virus 1, Herpes virus 2 Treponema pallidum
C. albicans, G. vaginalis T. vaginalis
Zika, Dengue Chikungunya Virus
West Nile
Yellow Fever
Mayaro Virus
Paciente #1
Paciente #1
Paciente #2
Paciente #2
Formatos disponibles
Pocillo.
Bajo
SHUÀO
Pocillo.
Alto
SHUÀO
Tubo
2ml
7XERSDUD
Rotor-Gene
6yORSDUDNLWV
Multiplex y Monoplex.
Disponible
en tira o placa.
Disponible
en tira o placa.
6yORSDUDNLWV
Multiplex y Monoplex.
10
Panels
(1
'LVSRQLEOHNLWFRQFRQWUROGHH[WUDFFLyQ 2
6yORSDUDXVRHQLQYHVWLJDFLyQ

11. Compatibilidades
/RVNLWVVIASURE proporcionan
ODPi[LPDÁH[LELOLGDGFRPSDWLELOLGDG
con los principales termocicladores
de sistema abierto.
“
11
7HUPRFLFODGRUHVFRQEORTXHGHEDMRSHUÀO
Fabricante Modelo
Agilent Technologies AriaMx / AriaDx
$SSOLHG%LRVVWHPV 7500 Fast (1)
$SSOLHG%LRVVWHPV 7500 Fast Dx (1)
$SSOLHG%LRVVWHPV QuantStudioTM
3 Fast (2)
$SSOLHG%LRVVWHPV QuantStudioTM
5 Fast
$SSOLHG%LRVVWHPV QuantStudioTM
6 Flex 96-well Fast
$SSOLHG%LRVVWHPV QuantStudioTM
7 Flex 96-well Fast
$SSOLHG%LRVVWHPV QuantStudioTM
12K Flex 96-well Fast
$SSOLHG%LRVVWHPV StepOne PlusTM (2)
$SSOLHG%LRVVWHPV StepOneTM (2)
$SSOLHG%LRVVWHPV ViiATM
7 Fast
%LRQHHU ExicyclerTM
96
%LR5DG CFX96TM
/ CFX96TM
IVD
%LR5DG Mini OpticonTM
Roche /LJKWFOHU®
480
Roche /LJKWFOHU®
96
Roche Cobas z480 Analyzer
)RUPDWRVHVSHFLDOHV
Fabricante Modelo
Qiagen Rotor-Gene®
Q
Cepheid Smartcycler® (3)
%06 Mic qPCR Cycler
7HUPRFLFODGRUHVFRQEORTXHGHDOWRSHUÀO
Fabricante Modelo
Abbott Abbott m2000
$SSOLHG%LRVVWHPV 7300 (2)
$SSOLHG%LRVVWHPV 7500
$SSOLHG%LRVVWHPV 7900 HT
$SSOLHG%LRVVWHPV $%,35,60
$SSOLHG%LRVVWHPV $%,35,60
$SSOLHG%LRVVWHPV QuantStudioTM
3 (2)
$SSOLHG%LRVVWHPV QuantStudioTM
5
$SSOLHG%LRVVWHPV QuantStudioTM
6 Flex 96-well
$SSOLHG%LRVVWHPV QuantStudioTM
7 Flex 96-well
$SSOLHG%LRVVWHPV QuantStudioTM
12K Flex 96-well
$SSOLHG%LRVVWHPV ViiaTM
7
$QDOWLN-HQD%LRPHWUD TOptical
$QDOWLN-HQD%LRPHWUD qTOWER 2.0
%LRQHHU ExicyclerTM
96
%LR5DG CFX96TM
Deep Well / CFX96TM
Deep Well IVD
%LR5DG iCycler iQTM
%LR5DG iCycler iQTM
5
%LR5DG MyiQTM
%LR5DG MyiQTM
2
DNA-Technology DTprime
DNA-Technology DTlite
(SSHQGRUI MastercyclerTM
ep realplex
Stratagene / Agilent
Technologies
Mx3000PTM
Stratagene / Agilent
Technologies
Mx3005PTM
VIASURE VIASURE 48
VIASURE VIASURE 96
/LVWDGRSDUDNLWV9,$685(PRQRSOH[
3DUDYHULÀFDUFRPSDWLELOLGDGFRQNLWVPXOWLSOH[
consultar instrucciones de uso.
(1)
Seleccionar Ramp Speed “Standard”.
(2)
No lectura en canal Cy5.
(3)
El producto se debe reconstituir siguiendo
el procedimiento adecuado y trasvasar
DORVWXERVHVSHFtÀFRV6PDUWFOHU®
.

12. VIASURE/GEN-1219ES
CerTest Biotec, S.L.
Pol. Industrial Río Gállego II · Calle J, Nº1
50840, San Mateo de Gállego, Zaragoza (Spain)
Tel. (+34) 976 520 354
Fax (+34) 976 106 268
certest@certest.es | viasure@certest.es
www.certest.es
One step ahead
9HQWDMDVEHQHÀFLRV
Kits de uso sencillo, listos para usar.
3URGXFWROLRÀOL]DGR
De 1 a 96 muestras por ensayo
$OWDVHQVLELOLGDGHVSHFLÀFLGDGUHSURGXFLELOLGDG
Validado según norma ISO 13485
y marcado CE
RQÀJXUDWXSDQHOGHGLDJQyVWLFR
Protocolo térmico similar
Caducidad: 24 meses
7UDQVSRUWHDOPDFHQDPLHQWRDWHPSHUDWXUDDPELHQWH
La tecnología de qPCR -o PCR a tiempo real-
se ha convertido en los últimos años
en el método diagnóstico más demandado
SRUVXDOWDVHQVLELOLGDGÀDELOLGDGEXHQD
reproducibilidad.
'HUHFKRVGHPRGLÀFDFLyQUHVHUYDGRV7RGRVORVGHUHFKRVUHVHUYDGRV‹HU7HVW%LRWHF6/
/RVSURGXFWRVVHUYLFLRVGDWRVPRVWUDGRVHQHVWHGRFXPHQWRSXHGHQVXIULUFDPELRVRPRGLÀFDFLRQHVVREUHORVWH[WRVHLPiJHQHVH[SXHVWRV